170 related articles for article (PubMed ID: 32515557)
1. Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis.
Makivic N; Stöllberger C; Nakuz T; Schneider B; Schmid C; Hasun M; Weidinger F
ESC Heart Fail; 2020 Aug; 7(4):1987-1991. PubMed ID: 32515557
[TBL] [Abstract][Full Text] [Related]
2. Serial scanning with
Minutoli F; Di Bella G; Mazzeo A; Laudicella R; Gentile L; Russo M; Vita G; Baldari S
J Nucl Cardiol; 2021 Oct; 28(5):1949-1957. PubMed ID: 31741327
[TBL] [Abstract][Full Text] [Related]
3. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
[TBL] [Abstract][Full Text] [Related]
4. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
6. Early-phase myocardial uptake intensity of
Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
[TBL] [Abstract][Full Text] [Related]
10. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Chen W; Ton VK; Dilsizian V
Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease.
Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Menezes MN; Guimarães T; Lima da Silva G; Francisco AR; Agostinho J; Santos L; Conceição I; Pinto FJ
Amyloid; 2020 Sep; 27(3):174-183. PubMed ID: 32482106
[No Abstract] [Full Text] [Related]
12. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
13. A Case of Wild-type Cardiac Transthyretin Amyloidosis Diagnosed by Non-invasive Methods.
Lizarazo Ortega DA; Valderrama BP; González-Robledo G; Trujillo PB
Curr Med Imaging; 2023; 19(4):402-406. PubMed ID: 35692154
[TBL] [Abstract][Full Text] [Related]
14. Apical sparing pattern of left ventricular myocardial
Van Der Gucht A; Cottereau AS; Abulizi M; Guellich A; Blanc-Durand P; Israel JM; Galat A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
J Nucl Cardiol; 2018 Dec; 25(6):2072-2079. PubMed ID: 28447284
[TBL] [Abstract][Full Text] [Related]
15. Prompt diagnosis of a wild-type transthyretin cardiac amyloidosis: Role of multimodality imaging.
Lim SS; Kuo L; Chang FP; Chang CC; Yu WC
J Chin Med Assoc; 2022 Nov; 85(11):1101-1105. PubMed ID: 36194162
[TBL] [Abstract][Full Text] [Related]
16. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
18. [Incidental Cardiac Uptake in Bone Scintigraphy Establishing a Diagnosis of Transthyretin Amyloid Cardiomyopathy: A Case Report].
Chono T; Harada K; Asanuma O
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Dec; 79(12):1370-1374. PubMed ID: 37766520
[TBL] [Abstract][Full Text] [Related]
19. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
[TBL] [Abstract][Full Text] [Related]
20. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
